$FGEN $SPY FGEN fell more than 40% on Friday, and told they came out with positive news: Eluminex Biosciences (Suzhou) Limited has exclusively licensed global rights to develop and commercialize a biosynthetic cornea from FibroGen Inc (NASDAQ: FGEN). Also, they are short sale exempt today 🤷🏽‍♂️
4
2
2 Likes